Mining public microarray data revealed that NCOR1-targeted genes were significantly enriched in Imatinib response gene signatures in cell lines and chronic myelogenous leukemia (CML) patients. The gene discussed is NCOR1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.